PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
1-Year Return
3.82%
This Quarter Return
-5.04%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$367M
AUM Growth
-$26.7M
(-6.8%)
Cap. Flow
+$39.4M
Cap. Flow
% of AUM
10.72%
Top 10 Holdings %
Top 10 Hldgs %
48.75%
Holding
121
New
27
Increased
18
Reduced
16
Closed
16
Top Buys
| 1 |
AtriCure
ATRC
|
$13.1M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.8M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$6.89M |
| 4 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$6.59M |
| 5 |
SI-BONE Inc
SIBN
|
$6.17M |
Top Sells
| 1 |
Grifois
GRFS
|
$13.5M |
| 2 |
AGN
Allergan plc
AGN
|
$13.3M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$7.52M |
| 4 |
CONMED
CNMD
|
$5.18M |
| 5 |
DexCom
DXCM
|
$4.82M |
Sector Composition
| 1 | Healthcare | 79.72% |
| 2 | Industrials | 2.66% |
| 3 | Consumer Staples | 0.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
QuidelOrtho
QDEL
$1.95B
| $5.09M | 0.6% |
+51,999
| New | +$5.09M |
|
27
Boston Scientific
BSX
$159B
| $4.08M | 0.48% |
+125,000
| New | +$4.08M |
|
|
AVDL
28
Avadel Pharmaceuticals
AVDL
$1.53B
| $3.94M | 0.47% |
496,660
+387,660
| +356% | +$3.08M |
|
29
Guardant Health
GH
$7.5B
| $3.79M | 0.45% |
54,475
-5,485
| -9% | -$382K |
|
30
Gilead Sciences
GILD
$143B
| $3.74M | 0.44% |
+50,000
| New | +$3.74M |
|
|
PPD
31
DELISTED
PPD, Inc. Common Stock
PPD
| $3.65M | 0.43% |
+205,000
| New | +$3.65M |
|
|
DMTK
32
DELISTED
DermTech, Inc. Common Stock
DMTK
| $3.48M | 0.41% |
+308,916
| New | +$3.48M |
|
33
10x Genomics
TXG
$1.74B
| $3.4M | 0.4% |
54,620
-32,720
| -37% | -$2.04M |
|
34
Castle Biosciences
CSTL
$683M
| $3.31M | 0.39% |
+110,899
| New | +$3.31M |
|
35
Cerus
CERS
$255M
| $3.15M | 0.37% |
+676,321
| New | +$3.15M |
|
36
Stereotaxis
STXS
$264M
| $3.11M | 0.37% |
1,029,281
+785,178
| +322% | +$2.37M |
|
|
MSON
37
DELISTED
Misonix Inc
MSON
| $3.01M | 0.36% |
+320,000
| New | +$3.01M |
|
|
IMVTU
38
DELISTED
Immunovant, Inc. Units
IMVTU
| $2.9M | 0.34% |
175,010
+9,840
| +6% | +$163K |
|
39
Apyx Medical
APYX
$74.1M
| $2.52M | 0.3% |
702,449
+128,667
| +22% | +$462K |
|
|
OTIC
40
DELISTED
Otonomy, Inc.
OTIC
| $2.46M | 0.29% |
1,246,858
+106,695
| +9% | +$210K |
|
|
AMRN
41
Amarin Corp
AMRN
$317M
| $2.43M | 0.29% |
30,316
+28,591
| +1,657% | +$2.29M |
|
|
NVRO
42
DELISTED
NEVRO CORP.
NVRO
| $2M | 0.24% |
+20,000
| New | +$2M |
|
43
Ardelyx
ARDX
$1.57B
| $1.84M | 0.22% |
323,641
+51,036
| +19% | +$290K |
|
|
ITMR
44
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $1.8M | 0.21% |
+152,947
| New | +$1.8M |
|
45
TG Therapeutics
TGTX
$5.11B
| $1.76M | 0.21% |
178,964
-98,675
| -36% | -$971K |
|
46
Cartesian Therapeutics
RNAC
$277M
| $1.51M | 0.18% |
+20,825
| New | +$1.51M |
|
47
OraSure Technologies
OSUR
$236M
| $1.45M | 0.17% |
+135,021
| New | +$1.45M |
|
48
Aurinia Pharmaceuticals
AUPH
$1.63B
| $1.44M | 0.17% |
98,913
-168,137
| -63% | -$2.44M |
|
49
Neurogene
NGNE
$285M
| $1.11M | 0.13% |
4,870
-1,539
| -24% | -$350K |
|
|
HZNP
50
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $972K | 0.12% |
+32,816
| New | +$972K |
|